ATOS Atossa Therapeutics, Inc.
Fundamentals / CIK 0001488039 / USDAtossa Therapeutics, Inc. reported $26.45M in total assets and a net loss of $34.66M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATOS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$35.90M Operating profit
-
Net Income FY 2025-$34.66M GAAP bottom line
-
Diluted EPS FY 2025-$3.47 Split-adjusted
-
Free Cash Flow FY 2025-$35.29M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$20.57M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | $21.18M | $14.12M | $17.33M | $15.08M | $9.21M | $6.61M | $6.65M | $4.21M | $2.33M | $770K |
| Total Operating Expenses | $37.14M | $27.62M | $31.38M | $27.69M | $20.52M | $14.61M | $17.27M | $11.43M | $7.65M | $7.97M |
| Operating Income | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M | -$14.61M | -$17.27M | -$11.43M | -$7.65M | -$7.97M |
| EBITDA | -$37.12M | -$27.60M | -$31.35M | -$27.68M | -$20.50M | -$14.56M | -$17.21M | -$11.39M | -$7.52M | -$7.67M |
| Interest Income | $2.38M | $4.05M | $4.34M | $877K | $6.0K | -- | -- | -- | -- | -- |
| Income Before Tax | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Net Income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Basic EPS | -$4.04 | -$3.04 | -$3.60 | -$3.15 | -$2.70 | -$29.55 | -$30.45 | -$82.50 | -$164.55 | -$32.40 |
| Diluted EPS | -$4.04 | -$3.04 | -$3.60 | -$3.15 | -$2.70 | -$29.55 | -$30.45 | -$82.50 | -$164.55 | -$32.40 |
| Basic Shares Outstanding | 8.6M | 8.4M | 8.4M | 8.4M | 7.8M | 754 | 566.5K | 277.2K | 65.0K | 196.5K |
| Diluted Shares Outstanding | 8.6M | 8.4M | 8.4M | 8.4M | 7.8K | 754 | 566.5K | 277.2K | 65.0K | 196.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $3.38M | $4.90M | $4.78M | $6.16M | $5.37M | $5.50M | $4.16M | $3.40M |
| Total Operating Expenses | $5.90M | $8.69M | $9.87M | $11.44M | $9.25M | $9.04M | $7.41M | $7.15M |
| Operating Income | -$5.90M | -$8.69M | -$9.87M | -$11.44M | -$9.25M | -$9.04M | -$7.41M | -$7.15M |
| EBITDA | -$5.89M | -$8.69M | -$9.87M | -$11.43M | -$9.25M | -$9.04M | -$7.41M | -$7.15M |
| Interest Income | $209K | $227K | $309K | $442K | $570K | $645K | $720K | $837K |
| Income Before Tax | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Basic EPS | -$0.56 | -$0.95 | -$1.11 | -- | -$1.01 | -$0.98 | -$0.78 | -- |
| Diluted EPS | -$0.56 | -$0.95 | -$1.11 | -- | -$1.01 | -$0.98 | -$0.78 | -- |
| Basic Shares Outstanding | 10.0M | 8.9M | 8.6M | -- | 8.6M | 8.6M | 8.6M | -- |
| Diluted Shares Outstanding | 10.0M | 8.9M | 8.6M | -- | 8.6M | 8.6M | 8.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $41.30M | $71.08M | $88.46M | $110.9M | $136.4M | $39.55M | $12.58M | $10.38M | $7.22M | $3.03M |
| Cash & Short-Term Investments | $41.30M | $71.08M | $88.46M | $110.9M | $136.4M | $39.55M | $12.58M | $10.38M | $7.22M | $3.03M |
| Other Current Assets | -- | -- | -- | $2.42M | $1.19M | $657K | $26K | $31K | $16K | -- |
| Total Current Assets | $45.62M | $74.46M | $92.22M | $118.2M | $141.2M | $42.77M | $14.32M | $11.55M | $7.90M | $3.25M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $20K | $21K | $34K | $54K | $11K | $55K |
| Intangible Assets | -- | -- | -- | -- | $54K | $41K | $174K | $192K | $234K | $640K |
| Other Non-Current Assets | $1.99M | $1.99M | $2.32M | $635K | $22K | $17K | $17K | $17K | $179K | $194K |
| Total Non-Current Assets | $1.99M | $1.99M | $4.03M | $5.33M | $22K | $69K | $171K | $171K | $266K | $890K |
| Total Assets | $47.61M | $76.44M | $96.25M | $123.5M | $141.3M | $42.84M | $14.49M | $11.72M | $8.16M | $4.14M |
| Accounts Payable | $4.29M | $679K | $806K | $2.96M | $1.72M | $1.59M | $293K | $353K | $335K | $254K |
| Other Current Liabilities | $1.10M | $1.51M | $1.80M | $19K | $21K | $4.0K | $13K | $40K | $16K | $6.1K |
| Total Current Liabilities | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M | $1.32M | $2.92M | $1.23M | $1.05M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $11K | $0 | $0 | $0 |
| Total Liabilities | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M | $1.33M | $2.92M | $1.23M | $1.05M |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | $18K | $50K | -- | -- | -- |
| Common Stock | $1.55M | $1.55M | $22.79M | $22.79M | $22.79M | $8.56M | $1.64M | $1.05M | $477K | $57K |
| Retained Earnings | -$246.6M | -$211.8M | -$186.3M | -$156.2M | -$129.2M | -$111.9M | -$94.07M | -$76.83M | -$65.43M | -$57.30M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $39.35M | $71.48M | $91.02M | $118.0M | $138.1M | $27.17M | $13.16M | $8.81M | $6.94M | $3.10M |
| Total Equity | $39.35M | $71.48M | $91.02M | $118.0M | $138.1M | $27.17M | $13.16M | $8.81M | $6.94M | $3.10M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $20.57M | $26.09M | $31.72M | $41.30M | $51.84M | $57.86M | $65.12M | $71.08M |
| Cash & Short-Term Investments | $20.57M | $26.09M | $31.72M | $41.30M | $51.84M | $57.86M | $65.12M | $71.08M |
| Total Current Assets | $25.18M | $31.01M | $36.67M | $45.62M | $55.68M | $62.52M | $68.74M | $74.46M |
| Other Non-Current Assets | $1.27M | $1.27M | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| Total Non-Current Assets | $1.27M | $1.27M | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| Total Assets | $26.45M | $32.28M | $37.94M | $47.61M | $58.01M | $64.52M | $70.75M | $76.44M |
| Accounts Payable | $1.50M | $1.98M | $2.57M | $4.29M | $3.54M | $2.01M | $1.17M | $679K |
| Other Current Liabilities | $745K | $1.12M | $1.14M | $1.10M | $1.57M | $1.56M | $1.53M | $1.51M |
| Total Current Liabilities | $4.71M | $5.45M | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.71M | $5.45M | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| Common Stock | $1.80M | $1.80M | $1.55M | $1.55M | $23.49M | $23.49M | $23.49M | $1.55M |
| Retained Earnings | -$270.3M | -$264.6M | -$256.2M | -$246.6M | -$235.6M | -$226.9M | -$218.5M | -$211.8M |
| Total Stockholders' Equity | $21.74M | $26.83M | $30.49M | $39.35M | $49.79M | $57.70M | $65.32M | $71.48M |
| Total Equity | $21.74M | $26.83M | $30.49M | $39.35M | $49.79M | $57.70M | $65.32M | $71.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Depreciation & Amortization | $16K | $17K | $23K | $8.0K | $23K | $47K | $53K | $44K | $129K | $303K |
| Stock-Based Compensation | $2.65M | $2.29M | $4.62M | $6.79M | $5.27M | $3.02M | $7.10M | $1.05M | $787K | $876K |
| Change in Payables | $3.61M | -$127K | -$2.16M | $1.25M | $128K | $1.29M | -$60K | $18K | $81K | -$560K |
| Operating Cash Flow | -$29.76M | -$21.03M | -$20.94M | -$20.76M | -$16.47M | -$11.57M | -$9.13M | -$8.96M | -$6.59M | -$5.37M |
| Capital Expenditure | -$23K | -$19K | -$14K | -$27K | -$9.0K | -$9.0K | -$7.6K | -$111K | -- | -- |
| Free Cash Flow | -$29.79M | -$21.05M | -$20.95M | -$20.79M | -$16.48M | -$11.58M | -$9.14M | -$9.07M | -- | -- |
| Investing Cash Flow | -$23K | -$19K | -$14K | -$4.73M | -$9.0K | -$9.0K | -$7.6K | -$111K | -- | -$9.2K |
| Common Stock Issued | -- | -- | -- | -- | $113.5M | -- | -- | -- | $6.16M | $4.70M |
| Share Repurchases | -- | $0 | -$1.48M | $0 | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $0 | $3.67M | -$1.48M | $0 | $113.3M | $38.55M | $11.34M | $12.29M | $10.78M | $4.70M |
| Net Change in Cash | -$29.79M | -$17.38M | -$22.43M | -$25.49M | $96.82M | $26.97M | $2.20M | $3.22M | $4.19M | -$688K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Depreciation & Amortization | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K |
| Stock-Based Compensation | $547K | $815K | $722K | $503K | $784K | $796K | $563K | $774K |
| Change in Payables | -$475K | -$593K | -$1.72M | $761K | $1.52M | $845K | $486K | -$882K |
| Operating Cash Flow | -$5.52M | -$9.64M | -$9.58M | -$10.54M | -$6.00M | -$7.26M | -$5.96M | -$7.05M |
| Capital Expenditure | $0 | $0 | $0 | -$7.0K | -$7.0K | $0 | -$9.0K | $0 |
| Free Cash Flow | -$5.52M | -$9.64M | -$9.58M | -$10.55M | -$6.01M | -$7.26M | -$5.97M | -$7.05M |
| Investing Cash Flow | $0 | $0 | $0 | -$7.0K | -$7.0K | $0 | -$9.0K | $0 |
| Financing Cash Flow | $0 | $4.02M | $0 | $0 | $0 | $0 | $0 | $3.37M |
| Net Change in Cash | -$5.52M | -$5.62M | -$9.58M | -$10.55M | -$6.01M | -$7.26M | -$5.97M | -$3.68M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -88.4% | -35.7% | -33.1% | -22.9% | -14.9% | -65.6% | -131.0% | -129.5% | -117.1% | -205.6% |
| Return on Assets (ROA) | -73.0% | -33.4% | -31.3% | -21.8% | -14.6% | -41.6% | -119.0% | -97.3% | -99.5% | -153.7% |
| Current Ratio | 5.53x | 14.99x | 17.61x | 21.23x | 45.18x | 2.73x | 10.83x | 3.96x | 6.45x | 3.11x |
| Quick Ratio | 5.00x | 14.31x | 16.89x | 19.92x | 43.63x | 2.52x | 9.51x | 3.56x | 5.89x | 2.89x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.00x | 0.00x | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -159.4% | -140.5% | -123.5% | -88.4% | -60.6% | -49.8% | -40.3% | -35.7% |
| Return on Assets (ROA) | -131.0% | -116.8% | -99.2% | -73.0% | -52.0% | -44.5% | -37.2% | -33.4% |
| Current Ratio | 5.35x | 5.69x | 4.92x | 5.53x | 6.77x | 9.17x | 12.67x | 14.99x |
| Quick Ratio | 4.37x | 4.79x | 4.25x | 5.00x | 6.30x | 8.48x | 12.00x | 14.31x |